FOLFIRINEC: a randomized phase II trial of mFOLFIRINOX vs platinum-etoposide for metastatic neuroendocrine carcinoma of gastroenteropancreatic or unknown origin
Julien Hadoux, Pauline Afchain, Thomas Walter, David Tougeron, Vincent Hautefeuille, Carole Montérymard, Véronique Lorgis, Frédéric Thuillier, Éric Baudin, Jean‐Yves Scoazec, Côme Lepage, Romain Desgrippes
Topics & Concepts
MedicineEtoposideInternal medicineContraindicationClinical endpointRegimenRandomized controlled trialNeuroendocrine tumorsOncologyProgression-free survivalChemotherapySurgeryPathologyAlternative medicineNeuroendocrine Tumor Research AdvancesLung Cancer Research StudiesThyroid Cancer Diagnosis and Treatment